Evaluation of the efficacy and safety of nivolumab in the second- or later-line treatment of patients with locally advanced/metastatic non-small cell lung cancer in Türkiye: a retrospective multicenter non-interventional registry study

---

Karadurmus N., Kaplan M., Sendur M., Urun Y., Demirci U., Karaca S., ...Daha Fazla

CURRENT MEDICAL RESEARCH AND OPINION, 2024 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Tam Makale
• Basım Tarihi: 2024
• Doi Numarası: 10.1080/03007995.2024.2359026
• Dergi Adı: CURRENT MEDICAL RESEARCH AND OPINION
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, CINAHL, EMBASE, International Pharmaceutical Abstracts, Public Affairs Index
• Anahtar Kelimeler: Nivolumab, non-small cell lung cancer, second-line therapy, efficacy, safety
• İstanbul Medipol Üniversitesi Adresli: Evet